BridgeMD
Compares treatment options for Stroke
Official title The Effects of Augmented Reality Versus Virtual Reality
ClinicalTrials.gov ID: NCT07113093
What this study is testing
- What it's testing
- This randomized controlled trial aims to compare the effects of augmented reality (AR) and virtual reality (VR)-assisted treadmill gait training on balance and walking in individuals with stroke, within the framework of the International Classification of Functioning, Disability and Health (ICF). A total of 66 post-stroke patients will be randomly assigned to three groups: (1) VR group receiving gait training via C-Mill VR applications in addition to conventional physiotherapy, (2) AR group receiving gait training via C-Mill AR applications in addition to conventional physiotherapy, and (3) control group receiving a home exercise program alongside conventional physiotherapy.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- ICD-10 diagnosis code of G.81 (Hemiplegia)
- Age 18 years or older
- Ability to walk with assistance or independently (Functional Ambulation Classification score of 2 or higher)
You likely can't join if
- Incomplete completion of the assessment form
- Refusal to participate in the study
- Aphasia
- Montreal Cognitive Assessment score below 10
- Presence of extra neurological or orthopedic problems unrelated to stroke
- Recurrent stroke
See the full eligibility criteria
- ICD-10 diagnosis code of G.81 (Hemiplegia)
- Age 18 years or older
- Ability to walk with assistance or independently (Functional Ambulation Classification score of 2 or higher)
- Incomplete completion of the assessment form
- Refusal to participate in the study
- Aphasia
- Montreal Cognitive Assessment score below 10
- Presence of extra neurological or orthopedic problems unrelated to stroke
- Recurrent stroke
- MAS score of 3-4 (lower extremity)
- Volunteer's desire to withdraw from the study
- Inability to adapt to the technological devices used in the study (e.g., visual or hearing impairments)
- Missing three consecutive treatment sessions
- Botulinum toxin-A (BONT-A) injection to the lower extremity during the treatment process or within the last 6 months
The study team makes the final eligibility decision.
Where it's taking place
- Ankara, Çankaya, Turkey (Türkiye)
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Ankara, Çankaya, Turkey (Türkiye). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.